Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Notable Labs, Ltd.

Notable Labs, Ltd. (NTBL) Stock Overview

Explore Notable Labs, Ltd.’s financial performance, market position, analyst ratings, and future outlook.

NTBL●NASDAQ
HealthcareBiotechnology
$0.25
$0.09(27.68%)
U.S. Market opens in 16h 58m

Notable Labs, Ltd. (NTBL)

Meyka AI Score

Z

Key Financials

Market Cap2.4M
P/E Ratio-0.05
EPS (TTM)$-1.09
ROE-0.60%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

NTBL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Notable Labs, Ltd. (NASDAQ: NTBL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Notable Labs, Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NTBL on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Notable Labs, Ltd.'s NASDAQ-traded stock include a P/E ratio of -0.05 and a market capitalization of 2.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NTBL on the NASDAQ.

Price Performance (NASDAQ: NTBL)

1-Day Change
N/A
5-Day Change
994.48%
1-Month Change
-27.68%
3-Month Change
-56.52%
6-Month Change
-74.44%
Year-to-Date (YTD) Change
-86.53%
1-Year Change
-93.44%
3-Year Change
-99.66%
5-Year Change
-99.40%
All-Time (Max) Change
-99.88%

Contact Information

https://www.notablelabs.com
NaN
6 Jonathan Netanyahu St, Or-Yehuda, NaN, 60376

Company Facts

160 Employees
IPO DateOct 1, 2014
CountryIL

Frequently Asked Questions